The invention provides 3-arylethynyl substituted quinazolinone compounds of formula (A) as potential anticancer agents against sixty human cancer cell lines. R1dbd.H, OH, OCH3; R2dbd.H, OH, CH3, OCH3, NO2; R3.dbd.H, OH, OCH3, F, Cl; R2+R3=--OCH2O--; R4.dbd.H, OH, CH3, OCH3; R5.dbd.H, OH, CH3, OCH3; R6.dbd.H, OCH3.
- Patent No:
- US8680272
- Application No:
- 13/984218
- Filing Date:
- 07-08-2013
- Issue Date:
- 25-03-2014
- Applicant:
- CSIR-Indian Institute of Chemical Technology (CSIR-IICT), Hyderabad
- Inventor(s):
- Kamal; Ahmed (Hyderabad, In), Sultana; Farheen (Hyderabad, In), Bharathi; Erla Vijaya (Hyderabad, In), Srikanth; Yellamelli Valli Venkata (Hyderabad, In), Viswanath; Arutla (Hyderabad, In), Swapna; Ponnampalli (Hyderabad, In)
- IPC Classification:
- C07D 239/91, C07D 401/10, C07D 405/10, C07D 409/10, C07D 401/06, C07D 405/06
- Country:
- United States of America
Accessibility Controls